H.pylori peptic ulcer disease pathophysiology: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
==Pathophysiology== | ==Pathophysiology== | ||
*H.pylori is closely associated with both duodenal and gastric ulcers.<ref name="pmid8547530">{{cite journal| author=Kuipers EJ, Thijs JC, Festen HP| title=The prevalence of Helicobacter pylori in peptic ulcer disease. | journal=Aliment Pharmacol Ther | year= 1995 | volume= 9 Suppl 2 | issue= | pages= 59-69 | pmid=8547530 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8547530 }} </ref> | |||
*The estimated lifetime risk for the development of peptic ulcer disease is 10-20%, in patients with H.pylori infection. | |||
*H.pylori can be diagnosed in 60-100% of gastric ulcer patients and 90-100% in duodenal ulcer patients. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 16:27, 12 January 2017
|
Helicobacter pylori infection Microchapters |
|
Differentiating Helicobacter pylori infection from other Diseases |
|---|
|
Diagnosis |
|
Guideline Recommendation |
|
Treatment |
|
Case Studies |
|
H.pylori peptic ulcer disease pathophysiology On the Web |
|
American Roentgen Ray Society Images of H.pylori peptic ulcer disease pathophysiology |
|
Directions to Hospitals Treating Helicobacter pylori infection |
|
Risk calculators and risk factors for H.pylori peptic ulcer disease pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]
Overview
Pathophysiology
- H.pylori is closely associated with both duodenal and gastric ulcers.[1]
- The estimated lifetime risk for the development of peptic ulcer disease is 10-20%, in patients with H.pylori infection.
- H.pylori can be diagnosed in 60-100% of gastric ulcer patients and 90-100% in duodenal ulcer patients.
References
- ↑ Kuipers EJ, Thijs JC, Festen HP (1995). "The prevalence of Helicobacter pylori in peptic ulcer disease". Aliment Pharmacol Ther. 9 Suppl 2: 59–69. PMID 8547530.